Joachim Bär

Global HP BioP Launch & Innovation

Boehringer Ingelheim Pharma GmbH & Co. KG

Biotechnologist by training Studied at technical University Braunschweig, University Lund-Sweden, University Waterloo-Kanada. PhD received from the mathematic technical University Halle-Wittenberg-Germany 2005 Scientist and project manager at the start Up company Probiodrug 2001-2006 Since 2006 with Boehringer Ingelheim in various roles in development and drug substance production for BI own projects as well as CMB and CDMB business Since 2018 director process development cell culture